Page last updated: 2024-12-11

piperovatine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

piperovatine: isolated from Ottonia frutescens; RN given refers to (E,E)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5374352
CHEMBL ID250442
SCHEMBL ID10594251
MeSH IDM0115464

Synonyms (16)

Synonym
piperovatine
CHEMBL250442
(2e,4e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienamide
1400-93-7
(2e,4e)-6-(4-methoxyphenyl)-n-(2-methyl-propyl)-hexa-2,4-dienoic acid amide
n-isobutyl-6-(4-methoxyphenyl)sorbamide
2,4-hexadienamide, 6-(4-methoxyphenyl)-n-(2-methylpropyl)-, (e,e)-
25090-18-0
SCHEMBL10594251
sorbamide, n-isobutyl-6-(p-methoxyphenyl)-, (e,e)-
IHRWUVSXOBLEJV-DVBIZMGNSA-N
(2e,4e)-n-isobutyl-6-(4-methoxyphenyl)-2,4-hexadienamide #
piperovatine [(2e,4e)-n-isobutyl-6-(4-methoxyphenyl)hexa-2,4-dienamide]
2,4-hexadienamide,6-(4-methoxyphenyl)-n-(2-methylpropyl)-,(2e,4e)-
isobutylamide piperovatine
(2e,4e)-n-isobutyl-6-(4-methoxyphenyl)hexa-2,4-dienamide

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID311988Antifungal activity against Cladosporium sphaerospermum after 72 hrs2007Journal of natural products, Dec, Volume: 70, Issue:12
Antifungal amides from Piper scutifolium and Piper hoffmanseggianum.
AID311989Antifungal activity against Cladosporium cladosporioides after 72 hrs2007Journal of natural products, Dec, Volume: 70, Issue:12
Antifungal amides from Piper scutifolium and Piper hoffmanseggianum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]